Bin‐Yan Zhong

1.9k total citations · 1 hit paper
74 papers, 1.0k citations indexed

About

Bin‐Yan Zhong is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Bin‐Yan Zhong has authored 74 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hepatology, 29 papers in Surgery and 24 papers in Epidemiology. Recurrent topics in Bin‐Yan Zhong's work include Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease and Transplantation (19 papers) and Liver Disease Diagnosis and Treatment (19 papers). Bin‐Yan Zhong is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (48 papers), Liver Disease and Transplantation (19 papers) and Liver Disease Diagnosis and Treatment (19 papers). Bin‐Yan Zhong collaborates with scholars based in China, United States and Hong Kong. Bin‐Yan Zhong's co-authors include Gao‐Jun Teng, Hai‐Dong Zhu, Cai‐Fang Ni, Jian Lü, Wansheng Wang, Xiaolong Qi, David C. Madoff, Xiaoli Zhu, Xiaoli Zhu and Zhi‐Cheng Jin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and Radiology.

In The Last Decade

Bin‐Yan Zhong

66 papers receiving 1.0k citations

Hit Papers

Combination locoregional and systemic therapies in hepato... 2025 2026 2025 4 8 12
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Combination locoregional and systemic therapies in hepatocellular carcinoma
    2025 14 citations Bin‐Yan Zhong, Wenzhe Fan et al. profile →

Peers

Bin‐Yan Zhong
E. Cohen United States
Hirokazu Chishina Japan
Florian Hucke Austria
Tomoki Kubota Japan
Judith Ertle Germany
Zhendong Chen China
Stefano Brocchi Italy
Chul Seung Kay South Korea
QiJiong Li China
Yukio Iwashita Japan
E. Cohen United States
Bin‐Yan Zhong
Citations per year, relative to Bin‐Yan Zhong Bin‐Yan Zhong (= 1×) peers E. Cohen

Countries citing papers authored by Bin‐Yan Zhong

Since Specialization
Citations

This map shows the geographic impact of Bin‐Yan Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin‐Yan Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin‐Yan Zhong more than expected).

Fields of papers citing papers by Bin‐Yan Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin‐Yan Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin‐Yan Zhong. The network helps show where Bin‐Yan Zhong may publish in the future.

Co-authorship network of co-authors of Bin‐Yan Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Bin‐Yan Zhong. A scholar is included among the top collaborators of Bin‐Yan Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin‐Yan Zhong. Bin‐Yan Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Bin‐Yan, Nan Jiang, Jintao Huang, et al.. (2025). Disphosphate based hydrogel microspheres for targeted transarterial radioembolization and chemoembolization therapies. Journal of Advanced Research.
2.
Zhong, Bin‐Yan, et al.. (2025). Relative differences in parenting time and fertility intention: evidence from China Family Panel Studies. Longitudinal and Life Course Studies. 17(1). 5–30.
3.
Xu, Xiaoyang, Ze Wang, Chengming Liu, et al.. (2024). Immune Indicator Changes in Hepatocellular Carcinoma Undergoing TACE Plus ICIs and Anti-VEGF Antibodies/TKIs: A Prognostic Biomarker Analysis. Journal of Hepatocellular Carcinoma. Volume 11. 2019–2032. 1 indexed citations
4.
Wang, Chunxin, et al.. (2024). The Value of Neutrophil-to-Lymphocyte Ratio in Predicting Mortality After Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Inflammation Research. Volume 17. 5211–5221. 2 indexed citations
5.
Jin, Zhi‐Cheng, et al.. (2024). Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European Gastroenterology Journal. 12(2). 226–239. 5 indexed citations
6.
Jin, Shuo, Jintao Huang, Yi Dong, et al.. (2024). Ultrastable PLGA-Coated 177Lu-Microspheres for Radioembolization Therapy of Hepatocellular Carcinoma. Molecular Pharmaceutics. 21(7). 3407–3415. 6 indexed citations
7.
Dong, Yi, Jintao Huang, Jing Sun, et al.. (2024). 99mTc/90Y radiolabeled biodegradable gel microspheres for lung shutting fraction assessment and radioembolization in hepatocellular carcinoma theranostics. Materials Today Bio. 29. 101367–101367. 3 indexed citations
8.
Qu, Weiwei, Dong Zhang, Bin‐Yan Zhong, et al.. (2024). Evaluation of Radiation Exposure and Influential Factors in Cone-Beam Computed Tomography (CBCT) of the Head and Abdomen during Interventional Procedures. Tomography. 10(3). 320–330. 1 indexed citations
9.
10.
Zhong, Bin‐Yan, Cai Wu, Dandan Yao, et al.. (2024). Dynamic changes of radiological and radiomics patterns based on MRI in viable hepatocellular carcinoma after transarterial chemoembolization. Abdominal Radiology. 50(5). 2110–2120. 1 indexed citations
11.
Huang, Jintao, Bin‐Yan Zhong, Junhui Sun, et al.. (2023). Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7. Journal of Hepatocellular Carcinoma. Volume 10. 1629–1638. 2 indexed citations
12.
Xu, Xiaoyang, Ze Wang, Jintao Huang, et al.. (2023). Prognosis Prediction of CRAFITY Score in HCC Undergoing TACE Combined with PD-(L)1 Inhibitors and Molecular Targeted Therapy. Journal of Hepatocellular Carcinoma. Volume 10. 2073–2082. 7 indexed citations
13.
Zhong, Bin‐Yan, Zhongzhi Jia, Ho-Young Song, et al.. (2023). Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation. HepatoBiliary Surgery and Nutrition. 0(0). 0–0.
14.
Huang, Jintao, Bin‐Yan Zhong, Nan Jiang, et al.. (2022). Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 9. 1217–1228. 22 indexed citations
15.
Chen, Li, Guangyu Zhu, Zhi‐Cheng Jin, et al.. (2022). Efficacy and Safety of Radioactive 125I Seed Implantation for Patients with Oligo-Recurrence Soft Tissue Sarcomas. CardioVascular and Interventional Radiology. 45(6). 808–813. 2 indexed citations
16.
17.
Jin, Zhi‐Cheng, Li Chen, Bin‐Yan Zhong, et al.. (2021). Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma. Frontiers in Oncology. 11. 602700–602700. 5 indexed citations
18.
Zhong, Bin‐Yan, Zhiping Yan, Junhui Sun, et al.. (2021). Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib. Frontiers in Molecular Biosciences. 8. 618050–618050. 8 indexed citations
19.
Zhang, Lei, Bin‐Yan Zhong, Wei Li, et al.. (2020). Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy. SHILAP Revista de lepidopterología. 3(4). 201–207. 1 indexed citations
20.
Meng, Xiangpan, Yuancheng Wang, Shenghong Ju, et al.. (2020). Radiomics Analysis on Multiphase Contrast-Enhanced CT: A Survival Prediction Tool in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Frontiers in Oncology. 10. 1196–1196. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Cohen Breakdown of academic impact, for papers by Hirokazu Chishina Breakdown of academic impact, for papers by Florian Hucke Breakdown of academic impact, for papers by Tomoki Kubota Breakdown of academic impact, for papers by Judith Ertle Breakdown of academic impact, for papers by Zhendong Chen Breakdown of academic impact, for papers by Stefano Brocchi Breakdown of academic impact, for papers by Chul Seung Kay Breakdown of academic impact, for papers by QiJiong Li Breakdown of academic impact, for papers by Yukio Iwashita
Rankless by CCL
2026